MESSAGE

It is a great honor that I have been appointed as the President of the 64th Meeting of the Japanese Society for Inherited Metabolic Diseases in conjunction with the 19th Asian Symposium of Inherited Metabolic Diseases, which will be held 5-7 October, 2023 at the Osaka International Convention Center. Since it is being held in Osaka, the theme of the meeting will be “Something New & Something Exciting!”(“Nanka-atarashi-mon, Nanka-omoroi-mon” in Osaka dialect) I hope that we can enjoy discussions with participants, focusing on something new and farsighted and on some unique ideas and approaches in circumstances surrounding medical care and studies of inherited metabolic diseases.

This year will mark the 64th Annual Meeting of the Japanese Society for Inherited Metabolic Diseases since the first meeting of the society, held in 1965 as the Pediatric Metabolism Research Society, by the predecessor of the society, Professor Toshio Takai of Department of Pediatrics, School of Medicine, Osaka City University (the present Osaka Metropolitan University). This 64th Annual Meeting represents the ninth time that Osaka has hosted the annual meeting of the society after the 6th, 17th, 20th and 25th events held in 1967, 1974, 1977 and 1982, when the Pediatric Metabolism Research Society was chaired by Professor Toshiaki Oura, Professor Keiya Tada, Professor Hyakuji Yabuuchi and Professor Gen Isshiki, respectively, and the 35th, 52nd and 57th events held in 1992, 2010 and 2015, when the Japanese Society for Inherited Metabolic Diseases was chaired by Professor Shintaro Okada, Professor Akemi Tanaka and Professor Haruo Shintaku, respectively. We would appreciate your cooperation as we will do our best to make the upcoming meeting even more successful than these past meetings. Together with Professor Takashi Hamazaki of Osaka Metropolitan University, who assumed the position of vice-president of the upcoming meeting, All Osaka is prepared to welcome participants to this 64th Annual Meeting.

The annual meetings have been affected by the outbreak of COVID-19 since 2020; however, as COVID-19 will be downgraded to a Category 5 infectious disease, we hope that many people will come to Osaka to participate in face-to-face exchanges and contemplate the future of medical care and studies of inherited metabolic diseases. Please come to find “Something New & Something Exciting!”

• The 64th Annual Meeting of the Japanese Society for Inherited Metabolic Diseases
  The 19th Asian Symposium of Inherited Metabolic Diseases
  PresidentNorio Sakai, MD, PhD
  (Specially Appointed Professor, Developmental Child Health Science,
  Department of Children's and Women's Health,
  Division of Health Sciences, Osaka University Graduate School of Medicine)